Latest Vertex Pharmaceuticals News & Updates

See the latest news and media coverage for Vertex. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Vertex Pharmaceuticals (Vertex)

Biopharmaceutical company

vrtx.com
Headquarters
Boston, United States
Founded year
1989
Company type
Public company
Number of employees
6,000–10,000

Last updated

Latest news about Vertex Pharmaceuticals (Vertex)

In short: Vertex reported strong Q1 2026 revenue of $2.99 billion and expanded its core cystic fibrosis franchise while advancing its non-CF drug pipeline.

Company announcements

  • Vertex

    Vertex announces CASGEVY reimbursement agreement in Germany

    The deal with GKV-Spitzenverband ensures access for patients 12+ with sickle cell disease or transfusion-dependent beta thalassemia.

  • Vertex

    Vertex reports Q1 2026 financial results

    Total revenue reaches $2.99 billion, up 8% from 2025. Reiterates full-year guidance of $12.95-13.1 billion. Pipeline advances include povetacicept BLA submission.

  • Vertex

    Vertex enters reimbursement agreement in Chile

    The agreement with Chile's Ministry of Health enables broad access to a cystic fibrosis therapy for eligible patients aged six and older.

  • Vertex

    Vertex announces FDA approval for ALYFTREK and TRIKAFTA label extensions

    Expands eligibility to ~95% of CF patients in the US, including 800 more for the first time. Supported by data from hundreds of variants.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Vertex

Track Vertex and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Vertex competitors & trending companies

Browse news for competitors to Vertex and other trending companies.